Cargando…
Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis
AIMS: The alarmin S100A8/S100A9 (S100A8/A9) is released by activated monocytes/macrophages and neutrophils in the setting lymphocytic myocarditis (MC). We recently demonstrated its therapeutic potential in experimental acute MC. Now, we investigated the diagnostic relevance of S100A8/A9 serum levels...
Autores principales: | Müller, Irene, Vogl, Thomas, Kühl, Uwe, Krannich, Alexander, Banks, Aron, Trippel, Tobias, Noutsias, Michel, Maisel, Alan S., van Linthout, Sophie, Tschöpe, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373886/ https://www.ncbi.nlm.nih.gov/pubmed/32462801 http://dx.doi.org/10.1002/ehf2.12760 |
Ejemplares similares
-
The alarmins S100A8 and S100A9 mediate acute pain in experimental synovitis
por: Blom, Arjen B., et al.
Publicado: (2020) -
Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity
por: Vogl, Thomas, et al.
Publicado: (2014) -
Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes
por: Christmann, Carolin, et al.
Publicado: (2021) -
S100A8 & S100A9: Alarmin mediated inflammation in tendinopathy
por: Crowe, Lindsay A. N., et al.
Publicado: (2019) -
The Spontaneous Course of Human Herpesvirus 6 DNA-Associated Myocarditis and the Effect of Immunosuppressive Intervention
por: Elsanhoury, Ahmed, et al.
Publicado: (2022)